Characterization of renal amyloid derived from the variable region of the lambda light chain subgroup II.
Amyloid fibrils were extracted from the kidney of a patient (CHE) shown to have tetramers and dimers of a monoclonal lambda light chain in his serum, and whose bone marrow cells in short-term culture synthesized these forms and a smaller lambda fragment of approximately 10,000 to 12,000 daltons. Biochemical and serologic analysis of a fraction of a size (obtained from amyloid fibrils extracted from the kidney) similar to that synthesized by the bone marrow cells revealed a light chain fragment corresponding to the amino terminal end of the variable region of the lambda light chain subgroup II. The presence of similarly sized short fragments of lambda light chain in both the synthesized and deposited protein suggests that aberrant synthesis and/or proteolytic degradation may play a pathogenetic role in the process of amyloidogenesis.
D000596:Amino Acids / Q000032:analysis; D000682:Amyloid / Q000032:analysis* / Q000302:isolation & purification; D006801:Humans; D007147:Immunoglobulin Light Chains / Q000302:isolation & purification*; D007146:Immunoglobulin lambda-Chains / Q000302:isolation & purification*; D007668:Kidney / Q000503:physiopathology; D008297:Male; D008875:Middle Aged; D009404:Nephrotic Syndrome / Q000276:immunology / Q000503:physiopathology
D000596:Amino Acids; D000682:Amyloid; D007147:Immunoglobulin Light Chains; D007146:Immunoglobulin lambda-Chains